Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
World Neurosurgery: X|March 6, 2023
Epidemiology, management, and treatment outcomes of metastatic spinal melanomaDavid X Zheng, Sauson Soldozy, Kathleen M Mulligan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 22, 2022
A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollmentMohamedraed Elshami, Jonathan J Hue, Richard S Hoehn, et al.
The Oncologist|November 26, 2025
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer CenterKevin G Zablonski, Jarred M Boone, Seunghee Margevicius, et al.
Annals of Surgical Oncology|December 16, 2025
Is Ultrasound-Based Imaging Essential for Melanoma Active Surveillance?Natalie N Chakraborty, Maira Bhatty, Kevin G Zablonski, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 12, 2022
Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinomaMohamedraed Elshami, Fasih A Ahmed, Hanna Kakish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
Surgery|November 19, 2022
Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignanciesMohamedraed Elshami, Fasih Ali Ahmed, Jonathan J Hue, et al.
Cancers|June 26, 2026
The Use and Utility of Adjuvant Checkpoint Inhibitors in Elderly Patients with Melanoma: A Single Institution ExperienceMaira A Bhatty, Natalie N Chakraborty, Kevin G Zablonski, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 21, 2022
Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancersMohamedraed Elshami, Fasih A Ahmed, Hanna Kakish, et al.
Surgery|November 29, 2021
A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problemsJonathan J Hue, Erryk S Katayama, Sarah C Markt, et al.
Pageof 10